Award
National Institute of Allergy and Infectious Diseases 5R01AI153100-05
Fosinopril analogs for the treatment of human babesiosis
Recipient
Yale University, New Haven, CT, United States
Award Amount
$725,898.00
Ceiling
$725,898.00
Awarded
March 31, 2025
Identifier
5R01AI153100-05
The project aims to develop and test analogs of fosinopril to treat babesiosis, improving efficacy and understanding mechanisms of action to support future clinical trials.
Description
This project focuses on developing safer and more effective therapies for babesiosis by exploring analogs of an existing drug, fosinopril, and understanding their mechanisms to facilitate future clinical trials.